Messenger ribonucleic acid vaccines against infectious diseases: current concepts and future prospects.

Authors:
Edwards DK; Carfi A.

Journal:
Curr Opin Immunol

Publication Year: 2022

DOI:
10.1016/j.coi.2022.102214

PMCID:
PMC9612403

PMID:
35671599

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Curr Opin Immunol

Abbreviation: Curr Opin Immunol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Allergy and Immunology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Inherited human ZNF341 deficiency.
Béziat V; Fieschi C; Momenilandi M and 4 more (2023) - Transparency Score: 3/6
Accelerating clinical trial development in vaccinology: COVID-19 and beyond.
Corey L; Miner MD. (2022) - Transparency Score: 3/6
Inflammation, immunity, and antigen persistence in post-acute sequelae of SARS-CoV-2 infectionImmun…
Newell KL; Waickman AT. (2022) - Transparency Score: 3/6
Insights into pandemic respiratory viruses: manipulation of the antiviral interferon response by SA…
Liu G; Gack MU. (2022) - Transparency Score: 3/6
Principles and practical applications of structure-based vaccine design.
Byrne PO; McLellan JS. (2022) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest statement All authors are employees of Moderna, Inc., and hold stock/stock options."

Evidence found in paper:

"Funding This work was funded by Moderna, Inc."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025